Rehabilitation  ||| S:0 E:15 ||| NN
in  ||| S:15 E:18 ||| IN
rheumatoid  ||| S:18 E:29 ||| JJ
arthritis  ||| S:29 E:39 ||| NN
and  ||| S:39 E:43 ||| CC
ankylosing  ||| S:43 E:54 ||| JJ
spondylitis ||| S:54 E:65 ||| NN
:  ||| S:65 E:67 ||| :
differences  ||| S:67 E:79 ||| NNS
and  ||| S:79 E:83 ||| CC
similarities  ||| S:83 E:96 ||| VBG
The  ||| S:96 E:100 ||| DT
aim  ||| S:100 E:104 ||| NN
of  ||| S:104 E:107 ||| IN
the  ||| S:107 E:111 ||| DT
paper  ||| S:111 E:117 ||| NN
is  ||| S:117 E:120 ||| VBZ
to  ||| S:120 E:123 ||| TO
summarize  ||| S:123 E:133 ||| VB
and  ||| S:133 E:137 ||| CC
compare  ||| S:137 E:145 ||| VB
the  ||| S:145 E:149 ||| DT
best  ||| S:149 E:154 ||| RBS
available  ||| S:154 E:164 ||| JJ
evidence  ||| S:164 E:173 ||| NN
concerning  ||| S:173 E:184 ||| VBG
the  ||| S:184 E:188 ||| DT
effectiveness  ||| S:188 E:202 ||| NN
of  ||| S:202 E:205 ||| IN
rehabilitative  ||| S:205 E:220 ||| JJ
interventions  ||| S:220 E:234 ||| NNS
and  ||| S:234 E:238 ||| CC
provide  ||| S:238 E:246 ||| VB
an  ||| S:246 E:249 ||| DT
overview  ||| S:249 E:258 ||| NN
of  ||| S:258 E:261 ||| IN
recommendations  ||| S:261 E:277 ||| NNS
or  ||| S:277 E:280 ||| CC
international  ||| S:280 E:294 ||| JJ
guidelines  ||| S:294 E:305 ||| NNS
on  ||| S:305 E:308 ||| IN
non-pharmacological  ||| S:308 E:328 ||| JJ
treatments  ||| S:328 E:339 ||| NNS
in  ||| S:339 E:342 ||| IN
rheumatoid  ||| S:342 E:353 ||| JJ
arthritis  ||| S:353 E:363 ||| NN
( ||| S:363 E:364 ||| -LRB-
RA ||| S:364 E:366 ||| NNP
)  ||| S:366 E:368 ||| -RRB-
and  ||| S:368 E:372 ||| CC
ankylosing  ||| S:372 E:383 ||| JJ
spondylitis  ||| S:383 E:395 ||| NNS
( ||| S:395 E:396 ||| -LRB-
AS ||| S:396 E:398 ||| NNP
) ||| S:398 E:399 ||| -RRB-
.It  ||| S:399 E:403 ||| NNP
was  ||| S:403 E:407 ||| VBD
found  ||| S:407 E:413 ||| VBN
that ||| S:413 E:417 ||| IN
,  ||| S:417 E:419 ||| ,
compared  ||| S:419 E:428 ||| VBN
to  ||| S:428 E:431 ||| TO
RA ||| S:431 E:433 ||| NNP
,  ||| S:433 E:435 ||| ,
there  ||| S:435 E:441 ||| EX
are  ||| S:441 E:445 ||| VBP
relatively  ||| S:445 E:456 ||| RB
fewer  ||| S:456 E:462 ||| JJR
non-pharmacological  ||| S:462 E:482 ||| JJ
intervention  ||| S:482 E:495 ||| NN
studies  ||| S:495 E:503 ||| NNS
in  ||| S:503 E:506 ||| IN
AS ||| S:506 E:508 ||| NNP
.  ||| S:508 E:510 ||| .
Overall ||| S:510 E:517 ||| RB
,  ||| S:517 E:519 ||| ,
the  ||| S:519 E:523 ||| DT
literature  ||| S:523 E:534 ||| NN
on  ||| S:534 E:537 ||| IN
the  ||| S:537 E:541 ||| DT
effectiveness  ||| S:541 E:555 ||| NN
of  ||| S:555 E:558 ||| IN
non-pharmacological  ||| S:558 E:578 ||| JJ
treatment  ||| S:578 E:588 ||| NN
modalities  ||| S:588 E:599 ||| NN
in  ||| S:599 E:602 ||| IN
RA  ||| S:602 E:605 ||| NNP
and  ||| S:605 E:609 ||| CC
AS  ||| S:609 E:612 ||| NNP
supports  ||| S:612 E:621 ||| VBZ
the  ||| S:621 E:625 ||| DT
use  ||| S:625 E:629 ||| NN
of  ||| S:629 E:632 ||| IN
exercise  ||| S:632 E:641 ||| NN
and  ||| S:641 E:645 ||| CC
educational  ||| S:645 E:657 ||| JJ
interventions  ||| S:657 E:671 ||| NNS
with  ||| S:671 E:676 ||| IN
a  ||| S:676 E:678 ||| DT
cognitive  ||| S:678 E:688 ||| JJ
behavioural  ||| S:688 E:700 ||| JJ
component ||| S:700 E:709 ||| NN
.  ||| S:709 E:711 ||| .
The  ||| S:711 E:715 ||| DT
evidence  ||| S:715 E:724 ||| NN
on  ||| S:724 E:727 ||| IN
electro-physical  ||| S:727 E:744 ||| JJ
modalities ||| S:744 E:754 ||| NN
,  ||| S:754 E:756 ||| ,
balneotherapy ||| S:756 E:769 ||| NN
,  ||| S:769 E:771 ||| ,
and  ||| S:771 E:775 ||| CC
dietary  ||| S:775 E:783 ||| JJ
interventions  ||| S:783 E:797 ||| NNS
and  ||| S:797 E:801 ||| CC
alternative  ||| S:801 E:813 ||| NN
or  ||| S:813 E:816 ||| CC
complementary  ||| S:816 E:830 ||| JJ
interventions  ||| S:830 E:844 ||| NNS
for  ||| S:844 E:848 ||| IN
managing  ||| S:848 E:857 ||| VBG
RA  ||| S:857 E:860 ||| NNP
and  ||| S:860 E:864 ||| CC
AS  ||| S:864 E:867 ||| NNP
is  ||| S:867 E:870 ||| VBZ
generally  ||| S:870 E:880 ||| RB
weak  ||| S:880 E:885 ||| JJ
or  ||| S:885 E:888 ||| CC
inconclusive.International  ||| S:888 E:915 ||| CD
practice  ||| S:915 E:924 ||| NN
guidelines  ||| S:924 E:935 ||| NNS
on  ||| S:935 E:938 ||| IN
RA  ||| S:938 E:941 ||| NNP
and  ||| S:941 E:945 ||| CC
AS  ||| S:945 E:948 ||| NNP
management  ||| S:948 E:959 ||| NN
recommend  ||| S:959 E:969 ||| VBP
non-pharmacological  ||| S:969 E:989 ||| JJ
interventions  ||| S:989 E:1003 ||| NNS
as  ||| S:1003 E:1006 ||| IN
adjunctive  ||| S:1006 E:1017 ||| JJ
interventions  ||| S:1017 E:1031 ||| NNS
to  ||| S:1031 E:1034 ||| TO
medications.Areas  ||| S:1034 E:1052 ||| CD
for  ||| S:1052 E:1056 ||| IN
future  ||| S:1056 E:1063 ||| JJ
research  ||| S:1063 E:1072 ||| NN
include  ||| S:1072 E:1080 ||| VBP
non-pharmacological  ||| S:1080 E:1100 ||| JJ
interventions  ||| S:1100 E:1114 ||| NNS
in  ||| S:1114 E:1117 ||| IN
AS ||| S:1117 E:1119 ||| NNP
,  ||| S:1119 E:1121 ||| ,
studies  ||| S:1121 E:1129 ||| NNS
on  ||| S:1129 E:1132 ||| IN
the  ||| S:1132 E:1136 ||| DT
effectiveness  ||| S:1136 E:1150 ||| NN
and  ||| S:1150 E:1154 ||| CC
costs  ||| S:1154 E:1160 ||| NNS
of  ||| S:1160 E:1163 ||| IN
various  ||| S:1163 E:1171 ||| JJ
health  ||| S:1171 E:1178 ||| NN
care  ||| S:1178 E:1183 ||| NN
delivery  ||| S:1183 E:1192 ||| NN
models ||| S:1192 E:1198 ||| NNS
,  ||| S:1198 E:1200 ||| ,
and  ||| S:1200 E:1204 ||| CC
the  ||| S:1204 E:1208 ||| DT
usage  ||| S:1208 E:1214 ||| NN
of  ||| S:1214 E:1217 ||| IN
alternative  ||| S:1217 E:1229 ||| NN
or  ||| S:1229 E:1232 ||| CC
complementary  ||| S:1232 E:1246 ||| JJ
treatments ||| S:1246 E:1256 ||| NNS
.  ||| S:1256 E:1258 ||| .
